JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Henderson, S. J.
Right arrow Articles by Lindup, W. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Henderson, S. J.
Right arrow Articles by Lindup, W. E.

Renal organic acid transport: uptake by rat kidney slices of a furan dicarboxylic acid which inhibits plasma protein binding of acidic ligands in uremia

SJ Henderson and WE Lindup

Department of Pharmacology and Therapeutics, University of Liverpool, England.

The furan dicarboxylic acid, 3-carboxy-4-methyl-5-propyl-2- furanpropanoic acid (5-propyl FPA), accumulates in uremic plasma and inhibits the binding of various drugs and marker ligands that are organic acids. 5-Propyl FPA is excreted unchanged in human urine and active tubular secretion is likely to be involved because of its high affinity for albumin. The uptake of 5-propyl FPA by rat kidney slices has been measured and compared with that of p-aminohippurate (PAH). The mean (+/- S.D.) slice/medium ratio for uptake of 5-propyl FPA (76 microM) was 22.7 +/- 2.6 (n = 11) and for PAH (75 microM) was 15.9 +/- 3.2 (n = 9) after incubation for 90 min at 25 degrees C. 5-Propyl FPA (149-829 microM) inhibited the uptake of PAH (77 microM) in a concentration-dependent manner, and likewise, PAH (150-830 microM) inhibited the uptake of 5-propyl FPA (77 microM). The mean apparent Km and Vmax values for the uptake of 5-propyl FPA were 194 +/- 125 microM and 55 +/- 28 nmol/g kidney/min, respectively, and 487 +/- 179 and 99 +/- 46 nmol/g kidney/min, respectively, for PAH. The kinetics of inhibition of uptake of PAH by 5-propyl FPA were mainly competitive. 5- Propyl FPA is thus likely to undergo active tubular secretion in a similar way to PAH, and this furan dicarboxylic acid, therefore, has the potential to inhibit the renal excretion of various drugs, drug conjugates and other endogenous organic acids.

Volume 263, Issue 1, pp. 54-60, 10/01/1992
Copyright © 1992 by American Society for Pharmacology and Experimental Therapeutics




This article has been cited by other articles:


Home page
 JCOHome page
R. M. Franke and A. Sparreboom
Inhibition of Imatinib Transport by Uremic Toxins During Renal Failure
J. Clin. Oncol., September 1, 2008; 26(25): 4226 - 4227.
[Full Text] [PDF]

Home page
 J. Pharmacol. Exp. Ther.Home page
Y. Tsutsumi, T. Deguchi, M. Takano, A. Takadate, W. E. Lindup, and M. Otagiri
Renal Disposition of a Furan Dicarboxylic Acid and Other Uremic Toxins in the Rat
J. Pharmacol. Exp. Ther., November 1, 2002; 303(2): 880 - 887.
[Abstract] [Full Text] [PDF]

Home page
 Nephrol Dial TransplantHome page
G. Lesaffer, R. De Smet, N. Lameire, A. Dhondt, P. Duym, and R. Vanholder
Intradialytic removal of protein-bound uraemic toxins: role of solute characteristics and of dialyser membrane
Nephrol. Dial. Transplant., January 1, 2000; 15(1): 50 - 57.
[Abstract] [Full Text] [PDF]

Home page
 J. Am. Soc. Nephrol.Home page
R. VANHOLDER and R. DE SMET
Pathophysiologic Effects of Uremic Retention Solutes
J. Am. Soc. Nephrol., August 1, 1999; 10(8): 1815 - 1823.
[Full Text]


Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
Molecular Interventions Drug Metabolism and Disposition

Copyright © 1992 by the American Society for Pharmacology and Experimental Therapeutics.